When three-year-old Zack Seabrook returned home to Sault Ste. Marie after months of leukemia treatment in London, Ont., the ...
Aptose Biosciences has scrapped a deal for a blood cancer drug candidate as part of its pending takeover by Hanmi ...
This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical ...
The 2025 Light The Night Executive Challenge raised $10.6 million for Blood Cancer United. Meet three leaders who stepped up.
The Independent on MSN
His wife’s cancer drug was quoted at $13,000. Then he found it for $40
His wife’s terminal cancer drug was quoted at $13,000 monthly. Then he found it for $40 - Exclusive: After the devastating ...
Abstracts highlight strong revumenib activity across the acute leukemia treatment continuum and multiple genetic subtypes –– New real-world ...
Advocates, survivors and community leaders are raising thousands of dollars for research, financial assistance and awareness ...
Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...
Emmalee Wilkins was diagnosed with myeloid leukemia in February. She's getting re-admitted to the hospital Monday to begin ...
The addition of an off-the-shelf pooled stem cell product to a single unit of umbilical cord blood conferred favorable ...
FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results